Does hepatic insulin resistance drive VLDL overproduction and more atherogenic LDL particles?

The connection between hepatic insulin resistance and atherogenic dyslipidemia is well-established through robust mechanistic and clinical evidence. In insulin-resistant states, the liver’s inability to respond to insulin’s suppressive signals leads to a cascade of lipid abnormalities characterized by VLDL overproduction and the emergence of more hazardous LDL subspecies.

VLDL overproduction and hepatic signaling

Hepatic insulin resistance (IR) directly increases the secretion of Very-Low-Density Lipoprotein (VLDL). Under normal conditions, insulin suppresses VLDL assembly by promoting the degradation of apolipoprotein B100 (ApoB100) via the PI3K-AKT pathway. In the IR state:

• Transcriptional dysregulation: Impaired insulin signaling fails to exclude FoxO1 from the nucleus, leading to the upregulation of microsomal triglyceride transfer protein (MTP), which is essential for VLDL assembly.
• Reduced degradation: Insulin-resistant hepatocytes show reduced sortilin-mediated lysosomal degradation of ApoB, increasing the available pool for particle secretion.

Formation of small dense LDL (sdLDL)

The surplus of VLDL particles serves as a substrate for a remodeling process that alters LDL quality.

• Lipid exchange: Elevated VLDL levels provide a rich pool of triglycerides. Cholesteryl ester transfer protein (CETP) facilitates the exchange of these triglycerides for cholesterol esters within LDL particles.
• Lipolytic remodeling: These triglyceride-enriched LDL particles are then hydrolyzed by hepatic lipase (HL). This reduces the particle volume and increases density, resulting in the characteristic small dense LDL (sdLDL) phenotype, which is more prone to oxidation and arterial wall penetration.

LDL particle number (LDL-P) and discordance

Increased VLDL secretion inherently leads to a higher total LDL particle count.

• ApoB stoichiometry: Each atherogenic particle (VLDL, VLDL remnants, and LDL) contains exactly one molecule of ApoB. Increased VLDL production inevitably cascades into a higher number of downstream LDL particles.
• Cholesterol discordance: Because sdLDL particles carry less cholesterol per particle, patients often present with a "discordant" profile—where total LDL cholesterol (LDL-C) appears normal despite a dangerously high total particle number (LDL-P).

Bottom line

Hepatic insulin resistance drives a metabolic shift that increases VLDL secretion, resulting in a higher number of small, dense LDL particles. This increases cardiovascular risk even when standard cholesterol markers (LDL-C) remain within target ranges.